Long-term mortality risk low after cerebral vein thrombosis

July 12, 2012
Long-term mortality risk low after cerebral vein thrombosis
For patients who survive a cerebral vein thrombosis, the long-term risk of mortality and recurrent venous thromboembolism seems to be low, according to a study published in the July issue of the Journal of Thrombosis and Haemostasis.

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the Journal of Thrombosis and Haemostasis.

Francesco Dentali, M.D., from the University of Insubria in Varese, Italy, and colleagues retrospectively assessed long-term , residual disability, and recurrent VTE in an international cohort of 706 patients (73.7 percent female) with a first CVT episode who were followed for a median of 40 months (range, six to 297 months).

Over the follow-up period, the researchers found that 2.8 percent of patients died, 89.1 percent had a complete recovery (modified Rankin Score [mRS], 0 to 1), and 3.8 percent had a partial recovery and were independent (mRS, 2). The mean treatment duration was 12 months, during which time 84 percent of patients were treated with oral anticoagulants. CVT recurred in 4.4 percent of patients, and 6.5 percent had VTE in a different site, corresponding with an overall incidence of recurrence of 23.6 events per 1,000 patient-years and of 35.1 events per 1,000 patient years after anticoagulant therapy withdrawal. The only significant predictor of in multivariate analysis was a previous VTE (hazard ratio, 2.70).

"The long-term risk of mortality and recurrent VTE appears to be low in patients who survived the acute phase of CVT," the authors write.

Explore further: Higher risk of VTE in CKD surgical patients on enoxaparin

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Higher risk of VTE in CKD surgical patients on enoxaparin

June 8, 2012
(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those ...

Venous thromboembolism up in adult hospitalizations

June 8, 2012
(HealthDay) -- Every year, more than half a million hospitalized U.S. adults acquire venous thromboembolism (VTE), a growing public health concern that is often preventable, according to research published in the June 8 issue ...

ACP recommends new approach to prevent venous thromboembolism in hospitalized patients

October 31, 2011
In a new clinical practice guideline published today in Annals of Internal Medicine, the American College of Physicians (ACP) recommends that doctors assess the risk of thromboembolism and bleeding in patients hospitalized ...

In colorectal surgery, risk for blood clots appears higher with open method versus laparoscopy

June 20, 2011
The risk of developing venous thromboembolism (VTE) may be nearly twice as high for patients undergoing open surgery for colorectal problems, versus those undergoing laparoscopic colorectal (LC) resections, according to a ...

Study confirms some contraceptive pills more likely to cause blood clots

October 25, 2011
A study published in the British Medical Journal today confirms previous findings that certain oral contraceptive pills are more likely to cause serious blood clots (venous thromboembolism - VTE ) than others.

Recommended for you

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

Lactic acid bacteria can protect against Influenza A virus, study finds

December 13, 2017
Lactic acid bacteria, commonly used as probiotics to improve digestive health, can offer protection against different subtypes of influenza A virus, resulting in reduced weight loss after virus infection and lower amounts ...

Aging impairs innate immune response to flu

December 13, 2017
Aging impairs the immune system's response to the flu virus in multiple ways, weakening resistance in older adults, according to a Yale study. The research reveals why older people are at increased risk of illness and death ...

Lyme bacteria survive 28-day course of antibiotics months after infection

December 13, 2017
Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of two papers published in the peer-reviewed journals PLOS ONE and American Journal of Pathology, that seem to support ...

Drug blocks Zika, other mosquito-borne viruses in cell cultures

December 12, 2017
If there was a Mafia crime family of the virus world, it might be flaviviruses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.